We are thrilled with the
More than 1,100 people with CF around the world volunteered for the clinical trials that led to Orkambi's approval, and we are deeply grateful for their invaluable contributions. We also thank the incredible team of scientists and clinical researchers and, most of all, the tens of thousands of families, friends, volunteers and donors whose hard work and generosity fueled this long, hard effort.
Orkambi is the second
Today's announcement gives us much to be proud of, along with tremendous momentum as we move forward urgently in our efforts to find powerful new therapies for all people with CF.
As we celebrate this exciting news, I hope you also feel proud of the vital role you have played in this major step forward. With the passionate commitment and support of this extraordinary community, I am confident that we will continue to forge new paths and reach our ultimate goal: a cure for all people with CF.
Robert J. Beall, Ph.D.
President and CEO